ATS 2024 Final Program

Click on the session title to view the speakers

171

MONDAY • MAY 20

P846 Independent Risk Factors for Critical Illness in Hospitalized Patients With COVID-19 in China P847 Chitotriosidase Regulates Host Response to Influenza Lung Infection P848 Impact of Corticosteroids on Cardiovascular Events in Critically Ill Patients With COVIDd-19 P849 Hyponatremia as a Predictive Marker of Mortality in Hospitalized COVID-19 Patients: A Healthcare System Analysis P850 Effects of Pneumothorax and Required Intervention in COVID-19 Patients P851 Can We Predict Lung Sequelae in Post-COVID-19 Patients? P852 The Role of Hyaluronic Acid in Predicting Mortality in SARS-COV-2 Omicron Variant Infections P853 Clinical Significance of Pre-existing Interstitial Lung Disease in Patients With COVID-19 P854 Biological Rhythms in Coronaviral Pneumonia P855 The Association Between COVID-19 Vaccination and Hospitalized Situation in Omicron Era: A Retrospective Study P856 Documented Failures and Thoughts on Preferred Anticoagulation Dosing for All Comers of COVID-19 Patients: A Meta-analysis P857 SARS-CoV-2 Spike Protein and Viral RNA Persist in the Lung of Patients With Post-COVID Lung Disease P858 Collectin Interaction With Human Rhinovirus P859 Thromboprophylaxis in COVID-19 Outpatients: A Systematic Review and Meta-analysis P860 Anticoagulation Strategies in Non-critically Ill COVID-19 Inpatients: A Systematic Review and Meta-analysis P861 Immunological Recovery Among Immunosuppressed Patients Who Survived COVID-19 Pneumonia P862 Recombinant Alpha-1 Antitrypsin as a Potential Therapy for Influenza Infection P863 Analysis of Baseline Factors Associated With Poor Clinical Outcome in a Phase 3 Trial in Patients Hospitalized Due to COVID-19 P864 The Proof Is in the Sputum: Untangling Viral Pneumonia From Bacterial Viral Co-infection

P865 Respiratory Syncytial Virus-related Disease in Patients With Chronic Obstructive Pulmonary Disease: Disease Burden and Possible Preventive Strategies P866 In Patients Hospitalized With Community-acquired Pneumonia, Detection of Respiratory Syncytial Virus and Influenza Increases When Testing Additional Respiratory Sample Types P867 Cannabis Use, Tobacco Use, and COVID-19 Infection: Findings From a Longitudinal Observation Cohort Study P868 Psychiatric Disorders Following Vaccination of Coronavirus Disease 2019 in South Korea: A National Retrospective Cohort Study P869 Recommendations on Treating Post-COVID-19 Symptoms According to Medical Associations in the United States P870 Combined Utility of Serum Ferritin and KL-6 Levels as Biomarkers for Predicting the Severity of COVID-19 P871 Perception of Influenza Vaccination Among Pulmonologists From Different Countries P872 Description of Immune Response and Multi-organ Damage Differences Between Infection of SARS-CoV-2, Influenza and the Other Respiratory Virus Using Machine Learning: A Retrospective Cohort Study P873 Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 Infection: A Systematic Review and Meta-analysis P874 Inhibiting End Binding Protein 3 (EB3) as a Pharmacological Intervention for COVID-19 Respiratory Complications P875 Investigation of the Pulmonary and Inflammatory Profile in a Murine Model of COVID-19 P876 Integrated In Vitro/Ex Vivo Assessment of Efficacy and Respiratory Toxicity for Accelerated Respiratory Drug Development P877 Prevalence, Microorganism Pattern and Mortality Among Ventilator Associated Pneumonia With Critically-ill COVID-19 Patients in Persahabatan National Respiratory Referral Hospital in Indonesia: A Retrospective Single Center Study

ATS 2024 Conference Program • San Diego, CA